Differential effects of IL-2 incubation on hematopoietic potential of autologous bone marrow and mobilized PBSC from patients with hematologic malignancies
Em. Areman et al., Differential effects of IL-2 incubation on hematopoietic potential of autologous bone marrow and mobilized PBSC from patients with hematologic malignancies, J HEMATOTH, 8(1), 1999, pp. 39-44
Citations number
27
Categorie Soggetti
Hematology,"Medical Research Diagnosis & Treatment
Culturing of hematopoietic progenitor cells for 24 h with IL-2 generates cy
totoxic effector cells that mediate in vitro and possibly in vivo antitumor
activity. We examined the effect of IL-2 incubation on progenitor cells fr
om 24 patients with hematologic malignancies using paired autologous bone m
arrow (ABM) and PBSC to determine differences in hematopoietic potential. C
ells were cryopreserved and stored in liquid nitrogen until conditioning th
erapy was completed. After thawing, cells were incubated with IL-2 for 24 h
at 37 degrees C. Paired samples of ABM and PBSC from the same patient were
analyzed for nucleated and mononuclear cell number, CD34 antigen expressio
n, and colony-forming unit (CFU) activity before and after IL-2 incubation.
There was a significant decrease in the average number of mononuclear cell
s (MNC) (x10(8)/kg) (<0.001) and CD34(+) cells (x 10(6)/kg) (0.006) from bo
th AEM and PBSC after 24 h IL-2 culture (ABM MNC: 0.6 +/- 0.1 vs. 0.4 +/- 0
.0, p = < 0.001; PBSC MNC: 4.4 +/- 0.5 vs. 3.7 +/- 0.4, p = 0.03; ABM CD34(
+): 2.4 +/- 0.5 vs. 1.3 +/- 0.3, p = < 0.001; PBSC CD34+: 6.6 +/- 1.8 vs. 5
.0 +/- 1.2, p = 0.05). However, whereas ABM CFU/10(5) MNC plated (269.3 +/-
47.2 vs. 385.6 +/- 70.6) were significantly increased (p = 0.005), there w
as no change in PBSC CFU (271.0 +/- 47.2 vs. 257.3 +/- 48.5). The mean plat
ing efficiency (%) of ABM CD34(+) cells was markedly increased after IL-2 i
ncubation (10.1 +/- 3.3 vs. 19.0 +/- 7.2, p = 0.04), although it was lower
than that of PBSC CD34(+) cells, which did not change significantly in cult
ure (29.4 +/- 5.5 vs. 36.0 +/- 6.5). Additional work is in progress to dete
rmine the cause and significance of the enhanced plating efficiency of the
ABM progenitor cells.